Inc. (NASDAQ:INCR) Files An 8-K Other Events

0
Inc. (NASDAQ:INCR) Files An 8-K Other Events

Inc. (NASDAQ:INCR) Files An 8-K Other Events
Item 8.01

On July 1, 2020, HarborOne Bancorp, Inc. (the “Company”) issued a press release announcing that its Board of Directors has declared a quarterly cash dividend of $0.03 per share, to be paid on July 28, 2020 to all shareholders of record as of the close of business on July 14, 2020.

A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01Financial Statements and Exhibits

(d)Exhibits

EXHIBIT INDEX

HarborOne Bancorp, Inc. Exhibit
EX-99.1 2 tmb-20200701xex99d1.htm EX-99.1 ​FOR IMMEDIATE RELEASE​​HarborOne Bancorp,…
To view the full exhibit click here

About Inc. (NASDAQ:INCR)

INC Research Holdings, Inc. is a global contract research organization (CRO). The Company is focused on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company’s Clinical Development Services segment offers all clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Company’s Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.